Logo image of CNR

CORE NATURAL RESOURCES INC (CNR) Stock Fundamental Analysis

USA - NYSE:CNR - US2189371006 - Common Stock

100.19 USD
+3.71 (+3.85%)
Last: 10/13/2025, 6:40:00 PM
98.5 USD
-1.69 (-1.69%)
After Hours: 10/13/2025, 6:40:00 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to CNR. CNR was compared to 211 industry peers in the Oil, Gas & Consumable Fuels industry. CNR has an average financial health and profitability rating. CNR is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

CNR had positive earnings in the past year.
In the past year CNR had a positive cash flow from operations.
CNR had positive earnings in 4 of the past 5 years.
CNR had a positive operating cash flow in each of the past 5 years.
CNR Yearly Net Income VS EBIT VS OCF VS FCFCNR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

1.2 Ratios

Looking at the Return On Assets, with a value of 0.33%, CNR is doing worse than 66.82% of the companies in the same industry.
The Return On Equity of CNR (0.55%) is worse than 65.88% of its industry peers.
Looking at the Return On Invested Capital, with a value of 1.90%, CNR is doing worse than 70.62% of the companies in the same industry.
CNR had an Average Return On Invested Capital over the past 3 years of 24.39%. This is above the industry average of 21.53%.
The 3 year average ROIC (24.39%) for CNR is well above the current ROIC(1.90%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 0.33%
ROE 0.55%
ROIC 1.9%
ROA(3y)17.24%
ROA(5y)10.53%
ROE(3y)35.71%
ROE(5y)22.09%
ROIC(3y)24.39%
ROIC(5y)15.83%
CNR Yearly ROA, ROE, ROICCNR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

1.3 Margins

CNR has a worse Profit Margin (0.63%) than 63.98% of its industry peers.
In the last couple of years the Profit Margin of CNR has grown nicely.
CNR has a worse Operating Margin (3.73%) than 68.72% of its industry peers.
In the last couple of years the Operating Margin of CNR has grown nicely.
CNR has a Gross Margin of 20.38%. This is in the lower half of the industry: CNR underperforms 65.88% of its industry peers.
CNR's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 3.73%
PM (TTM) 0.63%
GM 20.38%
OM growth 3Y12.32%
OM growth 5Y2.74%
PM growth 3Y70.14%
PM growth 5Y19.45%
GM growth 3Y-31.09%
GM growth 5Y-21.12%
CNR Yearly Profit, Operating, Gross MarginsCNR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

6

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so CNR is creating value.
CNR has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, CNR has more shares outstanding
CNR has a better debt/assets ratio than last year.
CNR Yearly Shares OutstandingCNR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
CNR Yearly Total Debt VS Total AssetsCNR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

An Altman-Z score of 2.13 indicates that CNR is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a decent Altman-Z score value of 2.13, CNR is doing good in the industry, outperforming 67.77% of the companies in the same industry.
The Debt to FCF ratio of CNR is 2.46, which is a good value as it means it would take CNR, 2.46 years of fcf income to pay off all of its debts.
CNR has a better Debt to FCF ratio (2.46) than 79.15% of its industry peers.
CNR has a Debt/Equity ratio of 0.09. This is a healthy value indicating a solid balance between debt and equity.
CNR has a Debt to Equity ratio of 0.09. This is in the better half of the industry: CNR outperforms 77.25% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF 2.46
Altman-Z 2.13
ROIC/WACC0.22
WACC8.74%
CNR Yearly LT Debt VS Equity VS FCFCNR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 1.78 indicates that CNR should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.78, CNR is in the better half of the industry, outperforming 72.51% of the companies in the same industry.
CNR has a Quick Ratio of 1.25. This is a normal value and indicates that CNR is financially healthy and should not expect problems in meeting its short term obligations.
CNR has a Quick ratio of 1.25. This is in the better half of the industry: CNR outperforms 63.03% of its industry peers.
Industry RankSector Rank
Current Ratio 1.78
Quick Ratio 1.25
CNR Yearly Current Assets VS Current LiabilitesCNR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

7

3. Growth

3.1 Past

CNR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -74.91%.
Measured over the past years, CNR shows a very strong growth in Earnings Per Share. The EPS has been growing by 22.60% on average per year.
The Revenue has grown by 45.25% in the past year. This is a very strong growth!
Measured over the past years, CNR shows a quite strong growth in Revenue. The Revenue has been growing by 9.16% on average per year.
EPS 1Y (TTM)-74.91%
EPS 3Y93.33%
EPS 5Y22.6%
EPS Q2Q%-135.71%
Revenue 1Y (TTM)45.25%
Revenue growth 3Y19.47%
Revenue growth 5Y9.16%
Sales Q2Q%119.98%

3.2 Future

CNR is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.84% yearly.
CNR is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 25.25% yearly.
EPS Next Y-112.17%
EPS Next 2Y5.83%
EPS Next 3Y4.41%
EPS Next 5Y9.84%
Revenue Next Year77.91%
Revenue Next 2Y39.26%
Revenue Next 3Y25.25%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CNR Yearly Revenue VS EstimatesCNR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B 4B
CNR Yearly EPS VS EstimatesCNR Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 5 10 15

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 29.55 indicates a quite expensive valuation of CNR.
Based on the Price/Earnings ratio, CNR is valued a bit more expensive than the industry average as 60.19% of the companies are valued more cheaply.
Compared to an average S&P500 Price/Earnings ratio of 27.35, CNR is valued at the same level.
With a Price/Forward Earnings ratio of 9.31, the valuation of CNR can be described as very reasonable.
CNR's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. CNR is cheaper than 74.88% of the companies in the same industry.
CNR's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.86.
Industry RankSector Rank
PE 29.55
Fwd PE 9.31
CNR Price Earnings VS Forward Price EarningsCNR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CNR is on the same level as its industry peers.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CNR is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 32.45
EV/EBITDA 9.42
CNR Per share dataCNR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)1.31
EPS Next 2Y5.83%
EPS Next 3Y4.41%

0

5. Dividend

5.1 Amount

CNR has a yearly dividend return of 0.56%, which is pretty low.
Compared to an average industry Dividend Yield of 6.15, CNR is paying slightly less dividend.
Compared to an average S&P500 Dividend Yield of 2.44, CNR's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.56%

5.2 History

CNR has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
CNR Yearly Dividends per shareCNR Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 0.5 1 1.5 2 2.5

5.3 Sustainability

148.79% of the earnings are spent on dividend by CNR. This is not a sustainable payout ratio.
DP148.79%
EPS Next 2Y5.83%
EPS Next 3Y4.41%
CNR Yearly Income VS Free CF VS DividendCNR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M
CNR Dividend Payout.CNR Dividend Payout, showing the Payout Ratio.CNR Dividend Payout.PayoutRetained Earnings

CORE NATURAL RESOURCES INC

NYSE:CNR (10/13/2025, 6:40:00 PM)

After market: 98.5 -1.69 (-1.69%)

100.19

+3.71 (+3.85%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)08-05 2025-08-05/bmo
Earnings (Next)11-03 2025-11-03/bmo
Inst Owners94.28%
Inst Owner Change0%
Ins Owners1.87%
Ins Owner Change-5.94%
Market Cap5.16B
Analysts77.78
Price Target99.35 (-0.84%)
Short Float %4.97%
Short Ratio3.4
Dividend
Industry RankSector Rank
Dividend Yield 0.56%
Yearly Dividend0.53
Dividend Growth(5Y)N/A
DP148.79%
Div Incr Years0
Div Non Decr Years0
Ex-Date08-29 2025-08-29 (0.1)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-158.97%
Min EPS beat(2)-207.45%
Max EPS beat(2)-110.49%
EPS beat(4)1
Avg EPS beat(4)-94.7%
Min EPS beat(4)-207.45%
Max EPS beat(4)0.73%
EPS beat(8)4
Avg EPS beat(8)-35.57%
EPS beat(12)8
Avg EPS beat(12)-12.67%
EPS beat(16)10
Avg EPS beat(16)-41.07%
Revenue beat(2)2
Avg Revenue beat(2)7.34%
Min Revenue beat(2)2.77%
Max Revenue beat(2)11.91%
Revenue beat(4)3
Avg Revenue beat(4)-1.81%
Min Revenue beat(4)-24.65%
Max Revenue beat(4)11.91%
Revenue beat(8)6
Avg Revenue beat(8)1.77%
Revenue beat(12)10
Avg Revenue beat(12)5.56%
Revenue beat(16)13
Avg Revenue beat(16)9.28%
PT rev (1m)2.8%
PT rev (3m)4.73%
EPS NQ rev (1m)-20%
EPS NQ rev (3m)-106.58%
EPS NY rev (1m)-18.51%
EPS NY rev (3m)-121.03%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.86%
Revenue NY rev (1m)0.02%
Revenue NY rev (3m)2.13%
Valuation
Industry RankSector Rank
PE 29.55
Fwd PE 9.31
P/S 1.57
P/FCF 32.45
P/OCF 13.12
P/B 1.37
P/tB 1.37
EV/EBITDA 9.42
EPS(TTM)3.39
EY3.38%
EPS(NY)10.76
Fwd EY10.74%
FCF(TTM)3.09
FCFY3.08%
OCF(TTM)7.64
OCFY7.62%
SpS63.72
BVpS73.2
TBVpS73.2
PEG (NY)N/A
PEG (5Y)1.31
Profitability
Industry RankSector Rank
ROA 0.33%
ROE 0.55%
ROCE 2.22%
ROIC 1.9%
ROICexc 2.06%
ROICexgc 2.06%
OM 3.73%
PM (TTM) 0.63%
GM 20.38%
FCFM 4.85%
ROA(3y)17.24%
ROA(5y)10.53%
ROE(3y)35.71%
ROE(5y)22.09%
ROIC(3y)24.39%
ROIC(5y)15.83%
ROICexc(3y)28.23%
ROICexc(5y)18.22%
ROICexgc(3y)28.23%
ROICexgc(5y)N/A
ROCE(3y)28.54%
ROCE(5y)18.52%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y35.93%
ROICexc growth 5Y15.67%
OM growth 3Y12.32%
OM growth 5Y2.74%
PM growth 3Y70.14%
PM growth 5Y19.45%
GM growth 3Y-31.09%
GM growth 5Y-21.12%
F-Score6
Asset Turnover0.53
Health
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF 2.46
Debt/EBITDA 0.64
Cap/Depr 58.19%
Cap/Sales 7.14%
Interest Coverage 250
Cash Conversion 74.92%
Profit Quality 770.76%
Current Ratio 1.78
Quick Ratio 1.25
Altman-Z 2.13
F-Score6
WACC8.74%
ROIC/WACC0.22
Cap/Depr(3y)74.91%
Cap/Depr(5y)64.93%
Cap/Sales(3y)7.37%
Cap/Sales(5y)8.18%
Profit Quality(3y)104.03%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-74.91%
EPS 3Y93.33%
EPS 5Y22.6%
EPS Q2Q%-135.71%
EPS Next Y-112.17%
EPS Next 2Y5.83%
EPS Next 3Y4.41%
EPS Next 5Y9.84%
Revenue 1Y (TTM)45.25%
Revenue growth 3Y19.47%
Revenue growth 5Y9.16%
Sales Q2Q%119.98%
Revenue Next Year77.91%
Revenue Next 2Y39.26%
Revenue Next 3Y25.25%
Revenue Next 5YN/A
EBIT growth 1Y-74.63%
EBIT growth 3Y34.19%
EBIT growth 5Y12.15%
EBIT Next Year38.6%
EBIT Next 3Y35.04%
EBIT Next 5Y24.59%
FCF growth 1Y-73.9%
FCF growth 3Y19.97%
FCF growth 5Y31.85%
OCF growth 1Y-49.63%
OCF growth 3Y15.95%
OCF growth 5Y14.26%